| Antimigraine drug consumption in Spain (1990-2000). | |
| | |
MedLine Citation:
|
PMID: 12580869 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: New marketed antimigraine drugs (triptans) are promising in the management of migraine pain. The impact of these new drugs on the overall consumption of the antimigraine drugs merits an analysis. MATERIAL AND METHODS: The package units of antimigraine drugs, sold and reimbursed by the Spanish National Health System, are used for estimations. Data are presented as defined daily doses per 10,000 inhabitants/day. RESULTS: During the 1990-2000 period, antimigraine drug utilization as a whole decreased by more than 25%; triptan use increased while ergot alkaloids' declined. CONCLUSIONS: The pattern of antimigraine drug utilization in Spain has changed noticeably in accordance with recent recommendations. |
| | |
Authors:
|
J García-del-Pozo; A Carvajal; C Grajal; E Vera; A del Pino |
Related Documents
:
|
21437429 - Prevalence of potential drug interactions in patients in an intensive care unit of a un... 17955169 - Uncontrolled headache induced by oxcarbazepine. 12045729 - The electrophysiology of migraine. 8337989 - Unconventional approaches to drug therapy in severe asthma. 351429 - Toward drugs derived from cannabis. 16526559 - Can corticosteroids be beaten in future asthma therapy? 2687429 - Sedative-hypnotics: pharmacology and use. 23031659 - Are drug provocation tests still necessary to test the safety of cox-2 inhibitors in pa... 3072349 - Population pharmacokinetics. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta neurologica Scandinavica Volume: 107 ISSN: 0001-6314 ISO Abbreviation: Acta Neurol. Scand. Publication Date: 2003 Feb |
Date Detail:
|
Created Date: 2003-02-12 Completed Date: 2003-04-15 Revised Date: 2006-08-16 |
Medline Journal Info:
|
Nlm Unique ID: 0370336 Medline TA: Acta Neurol Scand Country: Denmark |
Other Details:
|
Languages: eng Pagination: 158-60 Citation Subset: IM |
Affiliation:
|
Instituto de Farmacoepidemiología, Universidad de Valladolid, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic Agonists
/
therapeutic use* Analgesics / therapeutic use Drug Combinations Drug Utilization / statistics & numerical data, trends Humans Migraine Disorders / drug therapy*, prevention & control* National Health Programs / statistics & numerical data Serotonin Agonists / therapeutic use* Spain Vasoconstrictor Agents / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic Agonists; 0/Analgesics; 0/Drug Combinations; 0/Serotonin Agonists; 0/Vasoconstrictor Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multiple sclerosis, interferon beta and clinical thyroid dysfunction.
Next Document: Severe amphethamine-induced bruxism: treatment with botulinum toxin.